| Mrs Willetta Rozena Jacobs, ARNP | |
|
1847 S Lake Dr, Lexington, SC 29073-7759 | |
| (803) 356-8998 | |
| Not Available |
| Full Name | Mrs Willetta Rozena Jacobs |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 24 Years |
| Location | 1847 S Lake Dr, Lexington, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033326590 | NPI | - | NPPES |
| NP5401 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 21873 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Doctors Care, Pa | 6204731300 | 187 |
News Archive
Research staff from the Universitat Jaume I in the fields of information technology, psychology and business have developed a monitoring system based on indoor location using mobile devices.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced the availability of its AccuType® IL28B test for aiding in the prediction of patient response to peginterferon alpha-based therapy for hepatitis C virus (HCV) infection.
Amid concern about the potential toxic effects of the fluorochemicals used in nonstick cookware, water-repellent clothing, and other consumer products, manufacturers are using new versions of these chemicals that may be safer. That's the topic of the cover story in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
Pediatricians and researchers at The Children's Hospital of Philadelphia's(CHOP) have developed a first-of-its kind tool to help parents and health care providers better treat ADHD (attention deficit-hyperactivity disorder).
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
› Verified 4 days ago
| Entity Name | Doctors Care, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366499048 PECOS PAC ID: 6204731300 Enrollment ID: O20040112000069 |
News Archive
Research staff from the Universitat Jaume I in the fields of information technology, psychology and business have developed a monitoring system based on indoor location using mobile devices.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced the availability of its AccuType® IL28B test for aiding in the prediction of patient response to peginterferon alpha-based therapy for hepatitis C virus (HCV) infection.
Amid concern about the potential toxic effects of the fluorochemicals used in nonstick cookware, water-repellent clothing, and other consumer products, manufacturers are using new versions of these chemicals that may be safer. That's the topic of the cover story in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
Pediatricians and researchers at The Children's Hospital of Philadelphia's(CHOP) have developed a first-of-its kind tool to help parents and health care providers better treat ADHD (attention deficit-hyperactivity disorder).
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
› Verified 4 days ago
| Entity Name | It's Your Move |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396214987 PECOS PAC ID: 4880056837 Enrollment ID: O20230808003840 |
News Archive
Research staff from the Universitat Jaume I in the fields of information technology, psychology and business have developed a monitoring system based on indoor location using mobile devices.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced the availability of its AccuType® IL28B test for aiding in the prediction of patient response to peginterferon alpha-based therapy for hepatitis C virus (HCV) infection.
Amid concern about the potential toxic effects of the fluorochemicals used in nonstick cookware, water-repellent clothing, and other consumer products, manufacturers are using new versions of these chemicals that may be safer. That's the topic of the cover story in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
Pediatricians and researchers at The Children's Hospital of Philadelphia's(CHOP) have developed a first-of-its kind tool to help parents and health care providers better treat ADHD (attention deficit-hyperactivity disorder).
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Willetta Rozena Jacobs, ARNP 561 Hatteras Dr, Blythewood, SC 29016-9801 Ph: () - | Mrs Willetta Rozena Jacobs, ARNP 1847 S Lake Dr, Lexington, SC 29073-7759 Ph: (803) 356-8998 |
News Archive
Research staff from the Universitat Jaume I in the fields of information technology, psychology and business have developed a monitoring system based on indoor location using mobile devices.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced the availability of its AccuType® IL28B test for aiding in the prediction of patient response to peginterferon alpha-based therapy for hepatitis C virus (HCV) infection.
Amid concern about the potential toxic effects of the fluorochemicals used in nonstick cookware, water-repellent clothing, and other consumer products, manufacturers are using new versions of these chemicals that may be safer. That's the topic of the cover story in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
Pediatricians and researchers at The Children's Hospital of Philadelphia's(CHOP) have developed a first-of-its kind tool to help parents and health care providers better treat ADHD (attention deficit-hyperactivity disorder).
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
› Verified 4 days ago
Victoria Fenters, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1316 N Lake Dr, Lexington, SC 29072 Phone: 803-358-1191 | |
Dr. Brooke Patterson, DNP, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 815 Old Cherokee Rd, Lexington, SC 29072 Phone: 803-359-5181 | |
Mrs. Carolyn Birchmore, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1316 N Lake Dr, Lexington, SC 29072 Phone: 803-358-1191 Fax: 803-358-1180 | |
Amy Loper, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 811 W Main St Ste 207, Lexington, SC 29072 Phone: 803-358-6420 | |
Donna Marie Bridger, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2480 Two Notch Rd, Lexington, SC 29072 Phone: 803-951-5871 Fax: 803-951-5882 | |
Emilee Rikard Campbell, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 811 W Main St Ste 201&209, Lexington, SC 29072 Phone: 803-785-4777 Fax: 803-358-6240 |